Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cellular and Molecular Life Sciences : CMLS|December 30, 2017
Bacterial LPX motif-harboring virulence factors constitute a species-spanning family of cell-penetrating effectorsStefanie Norkowski, Britta Körner, Lilo Greune, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
The Shigella E3 ubiquitin ligase IpaH7.8 reprograms host kinase signaling to suppress NOX2-dependent oxidative burst responses in human monocytesTheresa Karagöz, Ivan Ngueya Yango, Stefanie Norkowski, et al.
International Journal of Medical Microbiology : IJMM|March 19, 2018
Multitalented EspB of enteropathogenic Escherichia coli (EPEC) enters cells autonomously and induces programmed cell death in human monocytic THP-1 cellsDoreen Baumann, Helen Salia, Lilo Greune, et al.
Plos Pathogens|December 19, 2013
Enterohemorrhagic Escherichia coli hemolysin employs outer membrane vesicles to target mitochondria and cause endothelial and epithelial apoptosisMartina Bielaszewska, Christian Rüter, Lisa Kunsmann, et al.
Angewandte Chemie (International Ed. in English)|November 2, 2021
Tumor-Cell-Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody-Inhibitor Conjugates (AiCs)Andreas Faust, Nicole Bäumer, Alina Schlütermann, et al.
The EMBO Journal|January 7, 2021
Crystal structure of bacterial cytotoxic necrotizing factor CNF<sub>Y</sub> reveals molecular building blocks for intoxicationPaweena Chaoprasid, Peer Lukat, Sabrina Mühlen, et al.
Scientific Reports|August 19, 2015
Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strainLisa Kunsmann, Christian Rüter, Andreas Bauwens, et al.
Plos Pathogens|February 4, 2017
Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injuryMartina Bielaszewska, Christian Rüter, Andreas Bauwens, et al.
Oncogene|February 27, 2022
Targeted siRNA nanocarrier: a platform technology for cancer treatmentNicole Bäumer, Jessica Tiemann, Annika Scheller, et al.
Journal of Hematology & Oncology|December 2, 2022
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemiaNicole Bäumer, Annika Scheller, Lisa Wittmann, et al.
Pageof 3